Schwartz Kira M. (0001813735)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 1520 NEW YORK NY 10016 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Prevail Therapeutics Inc. 0001714798 2020-06-01 officer: General Counsel

Items 1 - 3

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
D	2021-01-22		Prevail Therapeutics Inc.	4	D-Return	--D	100000.0000	0.0000	1	0001714798	Stock Option (Right to Buy)
A	2020-06-02		Prevail Therapeutics Inc.	4	A-Award	--D	100000.0000	100000.0000	1	0001714798	Stock Option (Right to Buy)
-	-		Prevail Therapeutics Inc.	3	-	---			1	-	-

http://www.sec.gov/cgi-bin/own-disp

---